Works matching IS 17588340 AND DT 2018 AND VI 10 AND IP 1
Results: 77
CDK4/6 inhibitors in breast cancer: beyond hormone receptor-positive HER2-negative disease.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918818346
- By:
- Publication type:
- Article
Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategies.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918816287
- By:
- Publication type:
- Article
Immunotherapy and pancreatic cancer: unique challenges and potential opportunities.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918816281
- By:
- Publication type:
- Article
Inhibitors targeting CDK4/6, PARP and PI3K in breast cancer: a review.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918808509
- By:
- Publication type:
- Article
Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of HER2-positive breast cancer with brain metastases (TRIO-US B-09).
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918807339
- By:
- Publication type:
- Article
Gene code CD274/PD-L1: from molecular basis toward cancer immunotherapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918815598
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918810117
- Publication type:
- Article
Assessing response to neo-adjuvant therapy in locally advanced rectal cancer using Intra-voxel Incoherent Motion modelling by DWI data and Standardized Index of Shape from DCE-MRI.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918809875
- By:
- Publication type:
- Article
Use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in older patients with ER-positive HER2-negative breast cancer: Young International Society of Geriatric Oncology review paper.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918809610
- By:
- Publication type:
- Article
Managing advanced HR-positive, HER2-negative breast cancer with CDK4/6 inhibitors in post-menopausal patients: is there a best sequence?
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918815591
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918804576
- Publication type:
- Article
Corrigendum.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918810116
- Publication type:
- Article
Durvalumab in NSCLC: latest evidence and clinical potential.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918804151
- By:
- Publication type:
- Article
Salvage surgery for recurrent or persistent tumour after radical (chemo)radiotherapy for locally advanced non-small cell lung cancer: a systematic review.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918804150
- By:
- Publication type:
- Article
Primary cilium and glioblastoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918801169
- By:
- Publication type:
- Article
Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918797589
- By:
- Publication type:
- Article
Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918794630
- By:
- Publication type:
- Article
Activation of viral defense signaling in cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918793105
- By:
- Publication type:
- Article
Towards precision medicine: linking genetic and cellular heterogeneity in gastric cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918794628
- By:
- Publication type:
- Article
Upregulation of LGALS1 is associated with oral cancer metastasis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918794622
- By:
- Publication type:
- Article
Updates on managing advanced breast cancer with palbociclib combination therapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918793849
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG-PET/CT imaging in cardiac tumors: illustrative clinical cases and review of the literature.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918793569
- By:
- Publication type:
- Article
Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918793326
- By:
- Publication type:
- Article
Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors following progression with imatinib, sunitinib and regorafenib.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918794623
- By:
- Publication type:
- Article
Alectinib in the treatment of ALK-positive non-small cell lung cancer: an update on its properties, efficacy, safety and place in therapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918789364
- By:
- Publication type:
- Article
Progression-free survival as a surrogate endpoint for overall survival in modern ovarian cancer trials: a meta-analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918788500
- By:
- Publication type:
- Article
Approved checkpoint inhibitors in bladder cancer: which drug should be used when?
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918788310
- By:
- Publication type:
- Article
CDK4/6 inhibition in breast cancer: current practice and future directions.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918786451
- By:
- Publication type:
- Article
The evolving immunotherapeutic landscape in advanced oesophagogastric cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918786228
- By:
- Publication type:
- Article
Synchronous liver metastases in patients with rectal cancer: can we establish which treatment first?
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918787993
- By:
- Publication type:
- Article
Preclinical and phase I clinical studies of KW-2450, a dual IGF-1R/IR tyrosine kinase inhibitor, in combination with lapatinib and letrozole.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918786858
- By:
- Publication type:
- Article
Use of cold-atmospheric plasma in oncology: a concise systematic review.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918786475
- By:
- Publication type:
- Article
Salvage surgery for local recurrence after stereotactic body radiotherapy for early stage non-small cell lung cancer: a systematic review.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918787989
- By:
- Publication type:
- Article
Dancing with the DNA damage response: next-generation anti-cancer therapeutic strategies.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918786658
- By:
- Publication type:
- Article
HDAC3-mediated silencing of miR-451 decreases chemosensitivity of patients with metastatic castration-resistant prostate cancer by targeting NEDD9.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918783132
- By:
- Publication type:
- Article
Neoadjuvant treatment of HER2-positive breast cancer: should therapy differ based on hormone receptor status?
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918782356
- By:
- Publication type:
- Article
The plasma Epstein–Barr virus DNA level guides precision treatment for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a large population-based cohort study from an endemic area.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918782331
- By:
- Publication type:
- Article
Therapy of breast cancer brain metastases: challenges, emerging treatments and perspectives.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918780312
- By:
- Publication type:
- Article
The role of abemaciclib in treatment of advanced breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918776925
- By:
- Publication type:
- Article
5-fluorouracil and cardiotoxicity: a review.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918780140
- By:
- Publication type:
- Article
Frequency, impact and a preclinical study of novel ERBB gene family mutations in HER2-positive breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918778297
- By:
- Publication type:
- Article
Optimal management of luminal breast cancer: how much endocrine therapy is long enough?
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918777437
- By:
- Publication type:
- Article
Immune-checkpoint inhibitors in melanoma and kidney cancer: from sequencing to rational selection.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918777427
- By:
- Publication type:
- Article
Prospective, single-center implementation and response evaluation of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918777036
- By:
- Publication type:
- Article
Rucaparib in ovarian cancer: an update on safety, efficacy and place in therapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918778483
- By:
- Publication type:
- Article
Should age impact breast cancer management in young women? Fine tuning of treatment guidelines.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918776923
- By:
- Publication type:
- Article
Radiotherapy and checkpoint inhibitors: a winning new combination?
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918768240
- By:
- Publication type:
- Article
Tumour necrosis factor, interferon-gamma and interleukins as predictive markers of antiprogrammed cell-death protein-1 treatment in advanced non-small cell lung cancer: a pragmatic approach in clinical practice.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918768238
- By:
- Publication type:
- Article
First-line treatment of ovarian cancer: questions and controversies to address.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918768232
- By:
- Publication type:
- Article
Estrogenicity of essential oils is not required to relieve symptoms of urogenital atrophy in breast cancer survivors.
- Published in:
- Therapeutic Advances in Medical Oncology, 2018, v. 10, n. 1, p. 1, doi. 10.1177/1758835918766189
- By:
- Publication type:
- Article